RxDoctor Payments Data

Nancy Pyram Bernard, DO

Family Medicine · Plantation, FLNPI 1538107115

Payments from drug & device makers

$7,352in general payments, 2019–2025

Across 123 payments — averaging $59.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cepheid$5K
  • Novo Nordisk$999
  • Lilly USA, LLC$418
  • Pfizer$151
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$146
  • Idorsia Pharmaceuticals US Inc$102
  • plus $536 from 13 others

What the payments were for

  • Food & beverage$2,31999%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,352 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$8,594
Medicare patients
31
Services billed
71

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$16,094
Atorvastatin Calcium38$326
Alprazolam16$291
Amlodipine Besylate35$191
Losartan Potassium25$165
Tramadol Hcl14$102
Lisinopril14$97
Rosuvastatin Calcium18$87
Levothyroxine Sodium11$81
Metformin Hcl25$67
Omeprazole16$41
Tizanidine Hcl14$30
Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid14$23

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$999$16,09415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Plantation

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →